Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab plus methotrexate versus placebo plus methotrexate on cartilage MRI in early rheumatoid arthritis
2013-004604-19Phase 3Terminated
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Adalimumab plus methotrexate with Placebo plus methotrexate (2 arms). Primary endpoint: Mean intergroup difference of pooled dGEMRIC index. Started Jun 2014; status: terminated.
02
Drugs
adalimumabmethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2013-004604-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004604-19.